San Antonio Hormone Replacement Therapy Clinic

San Antonio Hormone Replacement Therapy Clinic operates as a specialized hormone optimization center in San Antonio, Texas, focusing on bioidentical hormone replacement and peptide-based interventions for adults experiencing age-related hormonal decline. The clinic addresses conditions including low testosterone in men, menopausal symptoms in women, metabolic dysfunction, and body composition challenges through laboratory-guided treatment protocols. With a 4.7-star rating across 116 patient reviews, the practice has established a reputation for thorough diagnostic workups and individualized dosing strategies that account for each patient's baseline hormone levels, symptoms, and health objectives.

The clinic's peptide therapy program incorporates three specific growth hormone-related compounds: AOD-9604, a modified fragment of human growth hormone studied for its effects on fat metabolism and body composition; GHRP-2 (Growth Hormone Releasing Peptide-2), which stimulates endogenous growth hormone production and may support lean muscle preservation; and GHRP-6, another growth hormone secretagogue that patients use for metabolic support and recovery enhancement. These peptides are prescribed alongside comprehensive hormone panels that measure testosterone, estrogen, thyroid function, cortisol, and insulin markers. Treatment plans typically begin with baseline lab work, followed by a consultation to review results and determine appropriate peptide dosing, injection frequency, and monitoring intervals. The clinic provides patient education on subcutaneous injection technique and supplies all necessary administration materials.

For men's health, the clinic addresses hypogonadism, erectile dysfunction, decreased libido, muscle loss, and fatigue through testosterone replacement therapy combined with peptide protocols when indicated. Women's health services target perimenopause and menopause management, including estrogen and progesterone balancing, with peptides added to support metabolic rate and body composition goals that often shift during hormonal transitions. The medical team conducts follow-up labs at regular intervals—typically every three to six months—to assess treatment response and adjust dosing. Providers review lipid panels, liver function, and hematocrit levels to monitor for any adverse effects associated with hormone therapy.

Patients at San Antonio Hormone Replacement Therapy Clinic begin with an initial consultation that includes a detailed health history, symptom assessment, and discussion of treatment goals. The clinic requires comprehensive lab work before initiating any hormone or peptide therapy, which patients can complete at affiliated laboratories in the San Antonio area. Once results are available, providers develop a written treatment plan specifying medication types, dosages, administration schedules, and expected timelines for symptom improvement. Most patients report noticing initial changes in energy and mood within four to six weeks, with body composition and metabolic improvements becoming more apparent over three to six months. The clinic schedules regular follow-up appointments to assess progress, address side effects, and modify protocols based on patient response and updated lab values.

The clinic serves patients throughout Bexar County and surrounding areas of South Texas, with office hours structured to accommodate working professionals. All peptide medications are obtained from licensed compounding pharmacies that follow FDA guidelines for sterile preparation. The practice maintains a patient portal for lab result access, appointment scheduling, and secure messaging with clinical staff. San Antonio Hormone Replacement Therapy Clinic does not currently offer telehealth consultations, requiring in-person visits for initial evaluations and periodic follow-ups to ensure appropriate monitoring of hormone therapy. This hands-on approach allows providers to conduct physical examinations, review injection sites, and make real-time adjustments to treatment plans based on clinical presentation rather than remote reporting alone.